Sponsor

Northwell Health

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Northwell Health appears in 114 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials114
Recruiting shown11
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
MicroRNAs as Biomarkers in First Episode SchizophreniaNCT07703670 · lead sponsor · 2026-07-01
RECRUITING
Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.NCT05148156 · lead sponsor · 2026-02-11
RECRUITING
Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Pilot RCTNCT07254065 · lead sponsor · 2025-11-14
RECRUITING
Cerebellum-based Imaging Neural Markers for Antipsychotic ResponseNCT07483294 · lead sponsor · 2025-11-01
RECRUITING
Optimizing HFrEF Patients Using BaroStim and CardioMemsNCT07399587 · lead sponsor · 2025-01-17
RECRUITING
Biomarkers to Enhance Early Schizophrenia TreatmentNCT06969755 · lead sponsor · 2024-09-04
RECRUITING
iTBS to Enhance Social Cognition in People With PsychosisNCT06118268 · lead sponsor · 2023-04-18
RECRUITING
Tau Networks in Psychotic Alzheimer's DiseaseNCT05847192 · lead sponsor · 2023-04-13
RECRUITING
Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot StudyNCT05389787 · lead sponsor · 2022-08-18
RECRUITING
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk CohortNCT05384535 · lead sponsor · 2022-08-15
RECRUITING
Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis RiskNCT05131035 · lead sponsor · 2021-10-28
RECRUITING
Feasibility of a Diabetes Self-Management Program With Continuous Glucose Monitoring for Adults With Type 2 DiabetesNCT07743307 · lead sponsor · 2026-07-31
ENROLLING_BY_INVITATION
WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCTNCT07250113 · lead sponsor · 2026-02-17
ENROLLING_BY_INVITATION
Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing BlindnessNCT06023927 · lead sponsor · 2025-09-02
NOT_YET_RECRUITING
A BCT Intervention for an Hourly Activity Habit Among Caregivers for Persons With AD/ADRDNCT06801912 · lead sponsor · 2025-03-25
COMPLETED
BCT Intervention For Walking Habit Among Caregivers of People With AD/ADRDNCT06803797 · lead sponsor · 2025-03-18
COMPLETED
Reducing Burden in Care Partners of Community-Dwelling Persons With Dementia and Oropharyngeal DysphagiaNCT06557863 · lead sponsor · 2024-10-08
COMPLETED
Continuous Glucose Monitoring and Behavioral Change Intervention for People With Type 2 Diabetes and Diabetes DistressNCT05941000 · lead sponsor · 2024-09-10
COMPLETED
Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Intervention Development TrialNCT06486922 · lead sponsor · 2024-06-10
COMPLETED
Virtual Personalized Exercise Program for Lung Cancer PatientsNCT06540495 · lead sponsor · 2024-06-03
UNKNOWN
Reduce Loneliness in Care Partners of Persons With AD/ADRDNCT05460494 · lead sponsor · 2024-03-06
COMPLETED
SMART GOALS for Youth With PrediabetesNCT06067451 · lead sponsor · 2023-12-10
UNKNOWN
Eatable Alphabet as a Nutrition Education ToolNCT05166629 · lead sponsor · 2023-09-01
ACTIVE_NOT_RECRUITING
Comparing Post Cardiac Surgery Outcomes in ESRD Patient's With Early Dialysis Versus Standard CareNCT04705701 · lead sponsor · 2021-09-01
WITHDRAWN
Linguistic Predictors of Outcomes in PsychosisNCT05601050 · lead sponsor · 2021-03-04
COMPLETED
Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate CancerNCT04656678 · lead sponsor · 2020-11-25
UNKNOWN
Artificial Intelligence to Measure Adherence to Oral MedicationNCT04046497 · lead sponsor · 2020-11-20
UNKNOWN
Ascertaining Diagnosis Classification With Elicited SpeechNCT05601063 · lead sponsor · 2020-10-01
COMPLETED
Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 SurgeNCT04417270 · lead sponsor · 2020-06-12
COMPLETED
Using Digital Media Advertising to Reduce the Duration of Untreated PsychosisNCT03975400 · lead sponsor · 2020-04-22
COMPLETED
Post-operative Complications and Graft Survival With Conventional Versus Continuous Glucose Monitoring in Patients With Diabetes Mellitus Undergoing Renal TransplantationNCT04742023 · lead sponsor · 2020-04-21
COMPLETED
Neural Biomarkers of Electroconvulsive Therapy ResponseNCT04763655 · lead sponsor · 2020-04-01
UNKNOWN
Early-Phase Schizophrenia: Practice-based Research to Improve OutcomesNCT04004364 · lead sponsor · 2020-04-01
UNKNOWN
Feasibility of Using the CGM During TOC From in Persons With T2D Using InsulinNCT04533945 · lead sponsor · 2020-03-25
COMPLETED
Improving Decision-Making for Low Health Literate Prostate CA PatientsNCT05800483 · lead sponsor · 2020-03-01
COMPLETED
Genotypic Influences on Network Progression in Parkinson's DiseaseNCT04228172 · lead sponsor · 2020-02-24
ACTIVE_NOT_RECRUITING
Reducing Behavioral and Psychological Symptoms of Dementia: Family Caregivers (Aim 1)NCT04481568 · lead sponsor · 2020-02-03
COMPLETED
Computational Modeling of 60 Hz Subthalamic Nucleus Deep Brain Stimulation for Gait Disorder in Parkinson's DiseaseNCT04184791 · lead sponsor · 2020-01-15
COMPLETED
Financial Incentives to Improve Medication AdherenceNCT04191876 · lead sponsor · 2019-11-01
COMPLETED
Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)NCT04179721 · lead sponsor · 2019-10-22
COMPLETED
Diabetes Management Program for Hispanic/LatinoNCT03960424 · lead sponsor · 2019-09-30
COMPLETED
PICO Negative Pressure Wound Therapy in Obese Women Undergoing Elective Cesarean Delivery.NCT03414762 · lead sponsor · 2019-04-01
COMPLETED
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PENCT03581877 · lead sponsor · 2019-01-28
ACTIVE_NOT_RECRUITING
Boost rTMS for Auditory Verbal HallucinationsNCT03544333 · lead sponsor · 2018-04-16
TERMINATED
Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and ComorbiditiesNCT03387397 · lead sponsor · 2017-12-12
COMPLETED
The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End ProductsNCT02768220 · lead sponsor · 2017-12-01
WITHDRAWN
Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney DiseaseNCT03383627 · lead sponsor · 2017-11-30
COMPLETED
The CAROLE (CArdiac Related Oncologic Late Effects) StudyNCT03235427 · lead sponsor · 2017-06-27
COMPLETED
Telehealth Pulmonary Rehabilitation for Hispanic and African-American Patients Admitted With Exacerbation of COPDNCT03007485 · lead sponsor · 2017-04-01
COMPLETED
Striatal Connectivity and Clinical Outcome in PsychosisNCT02822092 · lead sponsor · 2016-07-01
COMPLETED
Safety and Tolerability of MSI-1436C in Metastatic Breast CancerNCT02524951 · lead sponsor · 2016-04-01
TERMINATED
A Prospective Trial of BiPAP Administration vs. Non-positive Pressure Therapy for Pediatric Status AsthmaticusNCT02539420 · lead sponsor · 2016-04-01
WITHDRAWN
Adjunctive Vortioxetine in SchizophreniaNCT02357797 · lead sponsor · 2016-02-01
UNKNOWN
Transcranial Direct Current Stimulation for Hallucinations in First-Episode SchizophreniaNCT02661347 · lead sponsor · 2016-02-01
WITHDRAWN
Super-selective Intra-arterial Cerebral Infusion of Trastuzumab for the Treatment of Cerebral Metastases of HER2/Neu Positive Breast CancerNCT02571530 · lead sponsor · 2015-08-01
TERMINATED
The Role of Echocardiographic Contrast (Optison) in Enhancing Tricuspid Regurgitation Spectral Doppler SignalsNCT02560116 · lead sponsor · 2015-06-01
WITHDRAWN
The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging StudyNCT02421146 · lead sponsor · 2015-04-01
COMPLETED
Pleth Variability and Asthma Severity in ChildrenNCT02302261 · lead sponsor · 2015-01-01
COMPLETED
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase PsychosisNCT02566057 · lead sponsor · 2014-07-10
COMPLETED
Telehealth Management in HF Disparity PatientsNCT02196922 · lead sponsor · 2014-01-01
COMPLETED

Drugs studied in this sponsor's trials

23 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Northwell Health as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
risperidone8
aripiprazole5
clozapine3
olanzapine3
albuterol1
alteplase1
budesonide1
empagliflozin1
risperidone RxCUI 35636 · Lead sponsor in 8 linked trial(s) · 2 currently recruiting 8 trials aripiprazole RxCUI 89013 · Lead sponsor in 5 linked trial(s) · 2 currently recruiting 5 trials clozapine RxCUI 2626 · Lead sponsor in 3 linked trial(s) · 1 currently recruiting 3 trials olanzapine RxCUI 61381 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials albuterol RxCUI 435 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial alteplase RxCUI 8410 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial budesonide RxCUI 19831 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial empagliflozin RxCUI 1545653 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial insulin, regular, human RxCUI 253182 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ipratropium bromide RxCUI 203212 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ketamine RxCUI 6130 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial linagliptin RxCUI 1100699 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial memantine RxCUI 6719 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial methohexital RxCUI 6847 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial montelukast RxCUI 88249 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial oxygen RxCUI 7806 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial paliperidone RxCUI 679314 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial placebo RxCUI 8375 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial prednisone RxCUI 8640 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial quetiapine RxCUI 51272 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial valproic acid RxCUI 11118 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial vortioxetine RxCUI 1455099 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ziprasidone RxCUI 115698 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor109
collaborator5
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.